Home
Conditions
Neurofibromatoses

Clinical trial condition

Neurofibromatoses

Explore clinical trials studying Neurofibromatoses. Study availability and eligibility vary by location and protocol.

45 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Neurofibromatoses trial results

Completed

Neurofibromatosis Type 1 Patient Registry

NCT01410006

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Washington University St Louis, Missouri, United States

View Trial Details

Completed

Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas

NCT01140360

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +16 more
Locations: Riley Hospital for Children Indianapolis, Indiana, United States

View Trial Details

Completed

Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

NCT01275586

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Riley Hospital for Children Indianapolis, Indiana, United States

View Trial Details

Completed

Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF

NCT02435628

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NCT02298270

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

NCT01673009

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: Indiana University Indianapolis, Indiana, United States

View Trial Details

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions: Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2

NCT00004437

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +37 more
Locations: Not specified

View Trial Details

Completed

Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas

NCT01412892

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +18 more
Locations: Henri Mondor Hospital Créteil, France

View Trial Details

Completed

Quality of Friendships in Children With Neurofibromatosis

NCT00508235

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: U.T.M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neurofibromatoses

Neurofibromatoses trial results

Related conditions